Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Synthetic skin patch shows promise for stubborn leg and foot ulcers

NCT ID NCT04927702

First seen Feb 28, 2026 · Last updated May 22, 2026 · Updated 7 times

Summary

This study tested a new synthetic fiber matrix (Restrata®) to help close diabetic foot ulcers and venous leg ulcers. For diabetic ulcers, it was compared to standard wound care; for venous ulcers, it was compared to a living skin substitute (Apligraf®). The goal was to see if the synthetic material could achieve complete wound closure more effectively. The study involved 48 adults and was terminated early.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Barry University

    Miami Beach, Florida, 33169, United States

  • Boston Medical Center

    Boston, Massachusetts, 02118, United States

  • Gundersen Health System

    La Crosse, Wisconsin, 54601, United States

  • ILD Research Center

    Vista, California, 92083, United States

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • University of Florida - Jacksonville

    Jacksonville, Florida, 32209, United States

Conditions

Explore the condition pages connected to this study.